港股医药生物板块走强，荣昌生物涨超6%

Group 1 - The Hong Kong pharmaceutical and biotechnology sector showed strong performance on November 26, with notable gains in several companies [1] - Rongchang Biopharmaceutical, CSPC Pharmaceutical Group, and 3SBio each saw their stock prices increase by over 6% [1] - Other companies such as Fuhong Hanlin, Cornerstone Pharmaceuticals, and China National Pharmaceutical Group also experienced significant price increases [1]